Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fatima Aït El Belghiti"'
Autor:
Pauline Leroux, Soraya Matczak, Bouchez Valérie, Antoine Ouziel, Elise Launay, Albert Faye, Valérie Rabier, Jean Sarlangue, Eric Jeziorski, Zoha Maakaroun-Vermesse, Fouad Madhi, Didier Pinquier, Mathie Lorrot, Marie Pouletty, Aymeric Cantais, Etienne Javouhey, Fatima Aït El Belghiti, Sophie Guillot, Carla Rodrigues, Sylvain Brisse, Jérémie F. Cohen, Julie Toubiana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3ae960fee706a658e5b185a820e3fcd
https://doi.org/10.2139/ssrn.4451238
https://doi.org/10.2139/ssrn.4451238
Autor:
Soraya Matczak, Corinne Levy, Camille Fortas, Jérémie F Cohen, Stéphane Béchet, Fatima Aït El Belghiti, Sophie Guillot, Sabine Trombert-Paolantoni, Véronique Jacomo, Yann Savitch, Juliette Paireau, Sylvain Brisse, Nicole Guiso, Daniel Lévy-Bruhl, Robert Cohen, Julie Toubiana
Publikováno v:
Eurosurveillance
Eurosurveillance, 2022, 27 (25), pp.2100933. ⟨10.2807/1560-7917.ES.2022.27.25.2100933⟩
Eurosurveillance, 2022, 27 (25), pp.2100933. ⟨10.2807/1560-7917.ES.2022.27.25.2100933⟩
Background Interventions to mitigate the COVID-19 pandemic may impact other respiratory diseases. Aims We aimed to study the course of pertussis in France over an 8-year period including the beginning of the COVID-19 pandemic and its association with
Autor:
Jérémie F. Cohen, Fatima Aït El Belghiti, Juliette Paireau, Camille Fortas, Yann Savitch, Sylvain Brisse, Soraya Matczak, Julie Toubiana, Stéphane Béchet, Nicole Guiso, Robert M. Cohen, Sophie Guillot, Daniel Levy Bruhl, Sabine Trombert, Véronique Jacomo, Corinne Levy
BackgroundInterventions to mitigate coronavirus disease 19 (COVID-19) pandemic may impact other respiratory diseases such as pertussis. We aimed to study the course of pertussis in France over an 8-year period and its association with COVID-19 mitiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d5e9784a02ed33da624bebd2a25f86f
https://doi.org/10.1101/2021.07.16.21260367
https://doi.org/10.1101/2021.07.16.21260367
Autor:
Julie Toubiana, Muhamed-Kheir Taha, Soraya Matczak, Daniel Lévy-Bruhl, Simon Cauchemez, Juliette Paireau, Henrik Salje, Sophie Guillot, Sylvain Brisse, Véronique Jacomo, Fatima Aït El Belghiti, Sabine Trombert-Paolantoni
Publikováno v:
The Lancet. Infectious diseases. 22(2)
Summary Background In April–May, 2013, France modified its pertussis vaccination schedule, which uses the acellular pertussis vaccine, from three primary doses at 2, 3, and 4 months of age and a first booster at 16–18 months of age (former schedu
Autor:
Henrik Salje, Sophie Guillot, Daniel Lévy-Bruhl, Julie Toubiana, Sylvain Brisse, Muhamed-Kheir Taha, Soraya Matczak, Sabine Trombert-Paolantoni, Fatima Aït El Belghiti, Véronique Jacomo, Simon Cauchemez, Juliette Paireau
Publikováno v:
The Lancet Infectious Diseases
The Lancet Infectious Diseases, 2022, 22 (2), pp.265-273. ⟨10.1016/S1473-3099(21)00267-X⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2022, 22 (2), pp.265-273. ⟨10.1016/S1473-3099(21)00267-X⟩
The Lancet Infectious Diseases, 2022, 22 (2), pp.265-273. ⟨10.1016/S1473-3099(21)00267-X⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2022, 22 (2), pp.265-273. ⟨10.1016/S1473-3099(21)00267-X⟩
Background: In 2013, France modified its pertussis vaccination schedule to remove one dose at 3 months of age and change the age of the booster dose from 16 to 11 months. We aimed to assess the subsequent impact on pertussis epidemiology in France. M
Autor:
Merdrignac, Lore, El Belghiti, Fatima Aït, Pandolfi, Elisabetta, Jané, Mireia, Murphy, Jane, Fabiánová, Kateřina, Cenoz, Manuel García, Flem, Elmira, Guillot, Sophie, Tozzi, Alberto E., Carmona, Gloria, Habington, Adele, Zavadilová, Jana, Navasués, Ana, Bøås, Håkon, Lévy-Brühl, Daniel, Ferretti, Beatrice, Lanaspa, Miguel, O'Sullivan, Niam, Křížová, Pavla
Publikováno v:
Eurosurveillance (15607917); 1/28/2021, Vol. 26 Issue 4, p1-12, 12p